▪ 2024-2029: Epidemiology of endometriosis in France (EPI-ENDO), targetted programme of the PEPR Women's health, couples' health (6.2 M€). Role: PI
▪ 2023-2028: Exposure to persistent organic pollutants and severity of endometriosis in the ComPaRe-Endometriosis cohort (POPENDO), French National Research Agency (684 k€). Role: PI
▪ 2023: Trajectories of endometriosis-associated pain and analysis of their correlates in the ComPaRe-Endometriosis cohort (TRAJENDO), Fondation de France (29 k€). Role: PI
▪ 2022-2024: Persistent organic pollutants and endometriosis: a metabolomic association study (EndoxOmics), Fondation pour la Recherche Médicale (542 k€). Role: Co-PI (PI: G. CANO-SANCHO, INRAE)
▪ 2020-2024: Genetic variants, early life exposures, and longitudinal endometriosis symptoms study (GELLES), Australian Ministry of Health, Medical Research Future Fund (AUD $1,86M ~1,13M€). Role: Co-PI (PI: G. MISHRA, The University of Queensland)
▪ 2020-2022: Influence of vitamin D on cutaneous melanoma risk and survival in the European EPIC (MELVITAD), French National Cancer Institute (INCa) (458 k€). Role: PI
▪ 2019-2021: The impact of comorbidity on cancer detection and survival (ComoCanS), French National Cancer Institute (INCa) (280 k€). Role: Co-PI (PI: H. FREISLING, International Agency for Research on Cancer)
▪ 2017-2020: Endocrine disrupting chemicals and risk of hormone-related cancers: the E3N prospective cohort (ED-CANCER), Inserm (French National Institute for Health and Medical Research) (637 k€). Role: PI
▪ 2017-2020: Health of cancer survivors: Fundamental knowledge from large French cohorts for the development of a tertiary prevention strategy in oncology (AFTER-CANCER), French Society for Cancer Research (Fondation ARC), French National Cancer Institute (INCa), and French Public Health Research Institute (IReSP) (634 k€). Role: PI
▪ 2017-2018: Confirmation and refinement of the model of heterogeneity for cutaneous melanoma in the European EPIC cohort: a pilot study (HETEROMEL), French League Against Cancer (60 k€). Role: PI
▪ 2015-2018: Sex steroid hormones and melanoma risk and survival in the European EPIC cohort (H-MELA), French National Cancer Institute (INCa) (381 k€). Role: PI
▪ 2012-2015: Epidemiological investigation into the association between endometriosis and cutaneous melanoma (MELENDO2), Marie Curie Fellowship, European Commission (269 k€). Role: PI
▪ 2010-2013: Genetic factors, pigmentary phenotype, sun exposure and skin cancer risk in the E3N cohort (MELAGEN), French National Cancer Institute (INCa) (237 k€). Role: PI